SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

LUNRs sharp rebound is being linked to the dismissal of a protest affecting the CLPS 2 program and speculation about upcoming NASA awards; no award announcement is confirmed in the discussion. Traders also point to short covering and a broader space-stock bounce, while others question whether the move will hold after the recent selloff.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Fireflys multiyear engine, technology-licensing and engineering-support agreement with AST SpaceMobile for its planned heavy-lift rocket is driving attention, with traders viewing it as validation of Fireflys propulsion business and a boost to funding and backlog prospects. Others remain cautious about execution, the rockets development timeline and the cash-and-stock payment structure, while the sharp rally has prompted debate over a possible short squeeze and profit-taking.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQs stronger-than-expected quarterly results and higher full-year revenue outlook are driving a sharp rebound, with traders also pointing to growing backlog and demand across the quantum sector. Many see the report as validation of the growth story, while others remain concerned about cash burn, dilution and whether acquisitions are translating into durable commercial revenue.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings quarterly earnings miss and sharply reduced outlook triggered a steep selloff, with traders focusing on the cost of expanding its Predictions business and questioning whether that spending can pay off. Bearish voices see worsening profitability and management credibility, while some dip buyers argue the core sportsbook remains strong and Predictions could build future market share.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris strong Q3 results, higher full-year revenue guidance and sharply improved long-term outlookdriven especially by Recorlev growthare fueling a sharp rally and bullish talk of a business re-rating. Traders are also speculating about a potential buyout and short covering, but those claims remain unconfirmed.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

A strong quarterly earnings beat, higher outlook, and expanded share-repurchase authorization have fueled a sharp rebound, with traders pointing to improving AI-driven ad performance and cash generation. Bulls see a re-rating after a prolonged selloff, while skeptics warn the rally may be overextended and vulnerable to profit-taking.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

A sharp selloff in AI and semiconductor stocks has weighed on AVGO, with traders debating whether uncertainty around data-center expansion and the sustainability of hyperscaler spending could slow demand for Broadcoms custom chips. Bears point to customer concentration and AI-financing risks, while bulls view the decline as overdone and are buying the dip.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

A Foxconn Tech Day display that traders identify as a POET optical engine in Foxconns photonics ecosystem has fueled hopes that the companys optical-interconnect technology is gaining traction. The community is split between viewing the display as a credibility boost and stressing that it is not evidence of new purchase orders or scaled shipments.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

Axons quarterly earnings miss and reduced full-year revenue outlook, attributed in community discussion to federal procurement delays, have driven a sharp selloff and fresh lows. Traders are divided between viewing the drop as a buying opportunity in a strong-growth business and arguing that the high valuation leaves room for further declines.

Karman Holdings, Inc. engages in the design, testing, manufacturing, and sale of dependable missile systems. It offers Payload Protection & Deployment Systems, Aerodynamic Interstage Systems, and Propulsion Systems. The company was founded on August 20, 2020 and is headquartered in Huntington Beach, CA.

Karman Holdings Inc.

Karman Holdings Ord Shs

Karmans strong Q3 results and raised full-year outlook are driving the rally, with traders highlighting rapid revenue growth, a sizable backlog, and defense-contract demand. The reaction is broadly bullish, though some question whether the sharp move is sustainable after recent volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aurora Cannabis Stock: What Organigram's Buyout Means for Investors

Aurora Cannabis shares surged after Organigram agreed to a C$561 million buyout, but competing bids, deal conditions and shareholder uncertainty remain.

Organigram Swoops In To Acquire Aurora Cannabis, Topping Curaleaf’s Rival Bid – ACB Stock Surges To Over 10-Month Highs

Equity

Organigram is set to acquire Aurora for C$7.80 per share, a 32.4% premium to the stock’s closing price on Monday.


Organigram to Acquire Aurora and Establish a Global Cannabis Leader

Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (Organigram) and Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) (Aurora) today announced that they have entered into an arrangement agreement (the Arrangement Agreement) pursuant to which Organigram will acquire all of the issued and outstanding common...

Organigram Provides Update on Integration of Sanity Group and Unified Global Operating Model

Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (the "Company" or "Organigram"), Canada's #1 cannabis company by market share1 and a growing global cannabis platform, today provided an update on the previously announced accelerated integration of Sanity Group GmbH (Sanity Group) and unified global...

Organigram Global to Premiere The 2026 OG Investor Session Today at 4:00 p.m. ET on X

Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (the "Company" or "Organigram") is pleased to announce that the 2026 OG Investor Session will premiere today, September 30, 2026, at 4:00 p.m. ET on the Company's X account at https://x.com/Organigram_Inc. This press release features multimedia. View...

Organigram Global to Host 2026 OG Investor Session

Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (the "Company" or "Organigram"), Canada's #1 cannabis company by market share and a growing global cannabis platform, today announced details of its 2026 OG Investor Session. This press release features multimedia. View the full release here...

Organigram Global Accelerates Integration of Sanity Group Under Unified Global Operating Structure

Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (Organigram or the Company) today announced an important milestone in its global growth strategy through the accelerated integration of Sanity Group GmbH (Sanity) and the alignment of leadership, operations and market development activities across the...

OrganiGram (OGI) Reports Q3 Loss, Beats Revenue Estimates

OrganiGram (OGI) delivered earnings and revenue surprises of -400.00% and +12.95%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers

Mereo BioPharma Group (NASDAQ:MREO) stock increased by 21.7% to $0.33 during Tuesday's pre-market session. The market value of their outstanding shares is at $43.4 million.
Organigram Global (NASDAQ:OGI)read more...

Organigram Reports Record Third Quarter Fiscal 2026 Results

Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), Canada's #1 cannabis company by market share2 and a growing global cannabis platform following its acquisition of Sanity Group GmbH (Sanity or Sanity Group), today announced its results for the third quarter ended June...

Organigram Global, Inc. engages in the provision of high-quality, indoor-grown cannabis for patients and adult recreational consumers and developing international business partnerships to extend the company’s global footprint. Its brands include Edison, Big Bag O’ Buds, SHRED, Monjour, and Trailblazer. The company was founded on July 5, 2010 and is headquartered in Toronto, Canada.

Organigram Global Inc.

Extremely Bullish Sentiment

<ul class="summary-bullets"><li>Aurora shareholders are expected to own roughly 35% of the combined company’s equity on a fully diluted basis.</li><li>The transaction is expected to be completed by January 2027.</li><li>Organigram edged out Curaleaf’s bid, which was revised to $5 per share last month.</li></ul>Shares of Aurora Cannabis (ACB) surged more than 20% on Tuesday, to their highest levels since December 2025, after Toronto-based Organigram Global (OGI) agreed to acquire the company for C$561 million ($400 million), potentially bringing an end to a prolonged takeover battle involving Curaleaf Holdings (CURLF).At the time of writing, CURLF shares were up around 13%, while OGI stock edged 1.3% lower.<h2 class="st-heading-2">Organigram Outbids Curaleaf</h2>Under the <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.businesswire.com/news/home/20261103746636/en/Organigram-to-Acquire-Aurora-and-Establish-a-Global-Cannabis-Leader">agreement</a>, Organigram will acquire Aurora for C$7.80 per share, a 32.4% premium to the stock’s closing price on Monday. It also represents a 93% premium to Aurora’s unaffected share price on August 10, the last full trading day before Curaleaf’s first bid, according to&nbsp; Organigram.Curaleaf initially <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/curaleaf-launches-take-over-bid-to-acquire-aurora-cannabis-invites-aurora-shareholders-to-tender-to-the-bid-302854033.html">launched</a> a takeover bid in August, offering $4 per Aurora share. In October, Curaleaf <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/curaleaf-enhances-offer-to-acquire-aurora-cannabis-302898362.html">raised</a> its offer to an implied $5 per share after Aurora rejected its initial proposal.However, Aurora’s board again rejected the revised bid, arguing that it undervalued the company’s business.<h2 class="st-heading-2">Deal Expected To Close In January 2027</h2>Organigram’s bid&nbsp;received unanimous approval from both companies’ boards, with the deal expected to close in January 2027. Aurora shareholders are expected to own roughly 35% of the combined company’s equity on a fully diluted basis.The combined company will operate five production and distribution facilities, with expected cost savings exceeding C$50 million. British American Tobacco (BATS), a strategic investor in Organigram, will provide C$187.5 million in financing to support the acquisition.The merger would combine Organigram’s recreational cannabis operations with Aurora’s international medical cannabis business, expanding their presence across Canada, Europe and Australia.<h2 class="st-heading-2">Retail Sees 4X Growth Potential In <a class="mention" data-mention="$ACB" data-symbol-id="ACB" href="https://stocktwits.com/symbol/ACB" target="_blank">ACB Stock</a></h2>Retail sentiment for ACB on Stocktwits turned ‘bullish’ from ‘neutral’ over the past 24 hours, amid a 433% surge in message volumes. Sentiment flipped to ‘bullish’ from ‘bearish’ for CURLF<img src="https://news.stocktwits-cdn.com/ACB_e1d803f011.png" alt="ACB.png"><img src="https://news.stocktwits-cdn.com/CURLF_e18ed9217c.png" alt="CURLF.png">One user highlighted BATS’ involvement and expects ACB to climb above $20. It is currently trading at $5.<stembedurl>https://stocktwits.com/Mikmee/message/668022941</stembedurl>ACB shares have jumped about 17% so far in 2026.Also read:<a href="https://stocktwits.com/news-articles/markets/equity/tesla-s-china-made-ev-sales-rise-for-12th-straight-month-european-recovery-adds-to-momentum/cNGXECcR95t">&nbsp;Tesla’s China-Made EV Sales Rise For 12th Straight Month – European Recovery Adds To Momentum</a>For updates and corrections, email newsroom[at]stocktwits[dot]com(Exchange rate: CAD1 = $0.7)

Kraken Robotics on Tuesday announced that it has entered into an agreement to acquire Covelya Group Limited.(Image Courtesy: Getty Images)

Organigram is set to acquire Aurora for C$7.80 per share, a 32.4% premium to the stock’s closing price on Monday.

Aurora Cannabis Inc

Curaleaf Holdings Inc

OrganiGram Holdings Inc.

Roundhill Cannabis ETF

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Stocktwits

Stocktwits Polls

$OGI $ACB  
OGI should be way up. BAT used their own money to buy ACB which only helps OGI sharehiolders, who will own 65% of the combined company. Not bad for a $1 stock

Steve G

$OGI USD on the left, Canadian dollar on the right

I would be lying if I said, I wasnt frustrated at times, especially since buying since 2019

But my goodness, the financial sheets are healthy, and the growth has persisted

It is not down because of this intrinsic value, it is down because most stocks in the Mary-j  sector are

But time wins all
And I will continue to hold and buy based off the last six years of growth￼

Matthew Prater

$OGI $ACB so I worked out Organigram Aurora so that it is favorable for both sides __ BAT injects 100 million so that ogi has 51% ownership they keep Organigram name and CEO while the ticket symbol is ACB __ there will be 110 million shares of new company opening at $4 USD __ ACB shareholders get 1.58 a share and .855 per share 10000 shares gets you $15800 cash and 8550 shares while ogi shareholders get 1 for 3 reverse split 30000 shares become 10000 shares at $4 _ own OGI and would vote for combined merger lead by BAT management

kenneth somers

$OGI This is not a short quick return on investment

The market cap of Aurora being added to Organigram  along with the amount of shares that they will be issuing washout

The question is can Organigram  grow revenue and profit quicker than their shared dilution 

As a bias shareholder, I would like to say yes lol ￼

$OGI __ I am really liking Organigram BAT $ACB more then ever espectally with CEO James Yamanaka at the helm __ BAT and Yamanaka DO NOT LOSE !

$OGI think it's worth remembering that everyone here is trying to make the best decisions they can

Chester Hudson

Organigram $OGI agreed to acquire Aurora Cannabis at C$7.80 per share, about C$561M. 
 
Next is the deal process: shareholder meetings are not yet set, closing expected in January 2027. 
 
Shares closed at $0.965 on Monday, below the SMA50 and below the SMA200, RSI 48. 
 
More details in our hub. 
 
Not investment advice.

Merlintrader Trading Pub

$OGI usually SP goes down after a company does an acquisition. Any guesses on the day low after trading resumes?

Feed

News

Sentiment

Earnings

Fundamentals

Info

OGI OrganiGram Holdings Inc.

Fundamentals

Latest OGI News